News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
62,050 Results
Type
Article (2177)
Company Profile (8)
Press Release (59865)
Section
Business (25397)
Career Advice (35)
Deals (3830)
Drug Delivery (3)
Drug Development (5076)
Employer Resources (6)
FDA (889)
Job Trends (1219)
News (33678)
Policy (1706)
Tag
Academia (89)
Accelerated approval (1)
Allergies (15)
Alliances (1855)
ALS (24)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (29)
Approvals (957)
Artificial intelligence (115)
Autoimmune disease (11)
Automation (9)
Bankruptcy (14)
Best Places to Work (1366)
Biosimilars (22)
Biotechnology (10)
Bladder cancer (51)
Brain cancer (9)
Breast cancer (145)
Cancer (968)
Cardiovascular disease (53)
Career advice (32)
Career pathing (1)
CAR-T (43)
Cell therapy (123)
Cervical cancer (11)
Clinical research (5489)
Collaboration (324)
Compensation (230)
COVID-19 (146)
CRISPR (19)
C-suite (81)
Cystic fibrosis (28)
Data (887)
Depression (9)
Diabetes (61)
Diagnostics (715)
Digital health (10)
Diversity (1)
Drug discovery (28)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (27)
Earnings (23800)
Employer resources (4)
Events (9483)
Executive appointments (324)
FDA (1430)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (301)
Gene editing (30)
Generative AI (4)
Gene therapy (86)
GLP-1 (91)
Government (162)
Grass and pollen (2)
Guidances (112)
Healthcare (1727)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (17)
Indications (11)
Infectious disease (190)
Inflammatory bowel disease (24)
Influenza (15)
Intellectual property (26)
Interviews (2)
IPO (3111)
Job creations (110)
Job search strategy (30)
Kidney cancer (7)
Labor market (2)
Layoffs (16)
Leadership (1)
Legal (386)
Liver cancer (16)
Lung cancer (137)
Lymphoma (77)
Machine learning (2)
Management (4)
Manufacturing (70)
MASH (15)
Medical device (1815)
Medtech (1815)
Mergers & acquisitions (1004)
Metabolic disorders (143)
Multiple sclerosis (30)
NASH (2)
Neurodegenerative disease (22)
Neuropsychiatric disorders (3)
Neuroscience (266)
NextGen: Class of 2025 (451)
Non-profit (192)
Now hiring (1)
Obesity (66)
Opinion (8)
Ovarian cancer (29)
Pain (18)
Pancreatic cancer (29)
Parkinson's disease (40)
Patents (60)
Patient recruitment (36)
Peanut (8)
People (2172)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (1391)
Phase II (2287)
Phase III (2159)
Pipeline (729)
Policy (1)
Postmarket research (186)
Preclinical (492)
Press Release (1)
Prostate cancer (51)
Psychedelics (1)
Radiopharmaceuticals (28)
Rare diseases (98)
Real estate (194)
Recruiting (3)
Regulatory (1581)
Reports (8)
Research institute (144)
Resumes & cover letters (1)
Rett syndrome (7)
RSV (15)
Schizophrenia (18)
Series A (51)
Series B (34)
Sickle cell disease (13)
Special edition (1)
Spinal muscular atrophy (11)
Sponsored (2)
Startups (125)
Stomach cancer (2)
Supply chain (25)
Vaccines (101)
Venture capital (2)
Weight loss (17)
Women's health (10)
Date
Last 7 days (100)
Last 30 days (529)
Last 365 days (10283)
2025 (5885)
2024 (6667)
2023 (4631)
2022 (5102)
2021 (5184)
2020 (4749)
2019 (3634)
2018 (2828)
2017 (2325)
2016 (1744)
2015 (2441)
2014 (1705)
2013 (1130)
2012 (1278)
2011 (1504)
2010 (1318)
Location
Africa (35)
Alabama (7)
Alaska (1)
Arizona (18)
Arkansas (4)
Asia (3604)
Australia (460)
California (2540)
Canada (506)
China (138)
Colorado (124)
Connecticut (134)
Delaware (113)
Europe (8027)
Florida (282)
Georgia (49)
Hawaii (1)
Idaho (4)
Illinois (230)
India (5)
Indiana (76)
Iowa (6)
Japan (114)
Kansas (7)
Kentucky (2)
Louisiana (6)
Maine (11)
Maryland (257)
Massachusetts (1999)
Michigan (56)
Minnesota (109)
Mississippi (1)
Missouri (26)
Montana (7)
Nebraska (2)
Nevada (22)
New Hampshire (15)
New Jersey (628)
New Mexico (5)
New York (650)
North Carolina (228)
North Dakota (2)
Northern California (1059)
Ohio (58)
Oklahoma (3)
Oregon (12)
Pennsylvania (348)
Puerto Rico (1)
Rhode Island (7)
South America (71)
South Carolina (3)
Southern California (890)
Tennessee (43)
Texas (366)
United States (8575)
Utah (49)
Virginia (65)
Washington D.C. (12)
Washington State (200)
West Virginia (1)
Wisconsin (53)
62,050 Results for "93".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CoRegen, Inc. Closes More Than $93 Million Financing
July 10, 2025
·
3 min read
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
North America Next Generation Sequencing Market Size Accelerates Toward USD 36.87 Billion at 21.93% CAGR by 2034
June 25, 2025
·
1 min read
Press Releases
Penicillin Drug Market to Reach USD 13.93 Billion by 2032, Growing at a CAGR of 3.3% | Coherent Market Insights
June 16, 2025
·
1 min read
Press Releases
NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress
April 30, 2025
·
3 min read
Press Releases
Marea Therapeutics Announces Late-Breaking Oral Presentation at the 93rd EAS Congress
April 15, 2025
·
1 min read
Layoffs
Organon Lets Go of 93 Employees in New Jersey in Continuing Workforce Cuts
Organon’s workforce cuts come several months after the company’s loss of exclusivity to its second-largest product, Atozet.
April 1, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases
March 26, 2025
·
3 min read
Press Releases
U.S. Biosimilars Market Size to Surpass USD 93.52 Billion by 2034
February 20, 2025
·
1 min read
Press Releases
APAC Viral Vectors & Plasmid DNA Manufacturing Market Sets for 21.93% CAGR by 2034
February 27, 2025
·
1 min read
1 of 6,205
Next
